tirzepatide side effects fever Effects: What to Expect & How to Manage (2026 Guide) Does Mounjaro Cause Fever? UK

The research is unambiguous on this point

Patients considering a mid-treatment switch should discuss the transition with their current provider and inform their new provider of their complete treatment history to ensure continuity of dosing and monitoring

Tirzepatide is a dual GIP and GLP-1 receptor agonist with a long pharmacological half-life

It is the option that fits the person, indication, safety profile, and monitoring plan

SGLT2-i reduces both systolic blood pressure (SBP) and diastolic blood pressure (DBP) across multiple trials and meta-analyses with reductions up to 8.6/4.3 mmHg, depending on the agent, dose and population studied

Your plan will be customized to your needs and regularly reviewed to keep you on track to better health